This is the authors' abstract. We don't add key points for this paper.
Here we detail an optimized transparent capacitive glucose oxidizing bioanode, capable of supplying current densities of 10 µA cm−2 at applied potentials of 0.1 V–0.2 V versus saturated calomel electrode, when continuously performing in a simple phosphate buffer, pH 7.4 and artificial human tears, both with a glucose concentration of 0.05 mM only. When operating in pulse mode, the bioanode was able to deliver current densities as high as 21 µA cm−2 at the beginning of the pulse with 571 µC cm−2 total charges stored. The biogenic part of the enzymatic device was a recombinant glucose oxidase mutant from Penicillium amagasakiense with high catalytic efficiency towards glucose, up to 14.5⋅104 M−1 s−1. The non‐biogenic part of the anodic system was based on a poly(3,4‐ethylenedioxythiophene)‐graphene nanocomposite, as a highly capacitive component with a capacitance density in the 1 mF cm−2 range, multi‐walled carbon nanotubes, as an additional nanostructuring element, and a conductive organic complex, as an electron shuttle between the redox enzyme and the electrode surface. The bioanode could potentially serve as a prototype of a double‐function enzymatic anode for hybrid electric power biodevices, energizing smart contact lenses.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
González‐Arribas et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: